Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JAYRIDE GROUP LIMITED Share Issue/Capital Change 2018

Dec 26, 2018

65156_rns_2018-12-26_74583450-2936-4cd2-860b-e5258b11a125.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Jayride Group Limited

ABN

49 155 285 528

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may be
issued
Class A Dir Performance Options
Class B Dir Performance Options
Class C Dir Performance Options
Class D Dir Performance Options
Class E Dir Performance Options
Class F Dir Performance Options
Class G Dir Performance Options
1,800,000 Class A Dir Performance Options
300,000 Class B Dir Performance Options
300,000 Class C Dir Performance Options
300,000 Class D Dir Performance Options
300,000 Class E Dir Performance Options
300,000 Class F Dir Performance Options
300,000 Class G Dir Performance Options
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

3
Principal terms of the+securities
(e.g. if options, exercise price and
expiry date; if partly paid
+securities,
the
amount
outstanding and due dates for
payment;
if
+convertible
securities, the conversion price
and dates for conversion)
Class A Dir Performance Options:
Options exercisable at $0.50 expiring 30 June
2021. Options will vest at a rate of 25,000
Options each quarter, with an effective
commencement of 1 January 2018. All Class A
Performance Options will vest by 31 December
2020.
Class B Dir Performance Options:
Options exercisable at $0.55 expiring 31
December 2021. Options vest upon the
Company’s share price being at or above the
exercise price at any time before the expiry date.
Class C Dir Performance Options:
Options exercisable at $0.60 expiring 31
December 2021. Options vest upon the
Company’s share price being at or above the
exercise price at any time before the expiry date.
Class DDir PerformanceOptions:
Options exercisable at $0.65 expiring 31
December 2021. Options vest upon the
Company’s share price being at or above the
exercise price at any time before the expiry date.
Class EDir PerformanceOptions:
Options exercisable at $0.80 expiring 31
December 2021. Options vest upon the
Company’s share price being at or above the
exercise price at any time before the expiry date.
Class FDir PerformanceOptions:
Options exercisable at $0.95 expiring 31
December 2021. Options vest upon the
Company’s share price being at or above the
exercise price at any time before the expiry date.
Class GDir PerformanceOptions:
Options exercisable at $1.10 expiring 31
December 2021. Options vest upon the
Company’s share price being at or above the
exercise price at any time before the expiry date.
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

4 Do the[+] securities rank equally in New classes of performance securities. On all respects from the[+] issue date conversion, the issued fully paid ordinary with an existing[+] class of quoted shares will rank equally with existing fully paid +securities? ordinary shares. If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration Securities issued for no cash consideration as part of the remuneration of the Directors, following shareholder approval at the 2018 Annual General Meeting. 6 Purpose of the issue Remuneration to Directors of the Company (If issued as consideration for the following shareholder approval at the 2018 acquisition of assets, clearly Annual General Meeting. identify those assets) 6a Is the entity an[+] eligible entity Yes. that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder 28 November 2018 resolution under rule 7.1A was passed 6c Number of[+] securities issued Nil. without security holder approval under rule 7.1 6d Number of[+] securities issued Nil. with security holder approval under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

6e Number of[+] securities issued 1,800,000 Class A Dir Performance Options with security holder approval 300,000 Class B Dir Performance Options under rule 7.3, or another 300,000 Class C Dir Performance Options specific security holder approval 300,000 Class D Dir Performance Options (specify date of meeting) 300,000 Class E Dir Performance Options 300,000 Class F Dir Performance Options 300,000 Class G Dir Performance Options Shareholder approval received on 28 November 2018 at Jayride 2018 AGM. 6f Number of[+] securities issued N/A under an exception in rule 7.2 6g If[+] securities issued under rule N/A 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If[+] securities were issued under N/A rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining 7.1 Capacity: 10,684,406 issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 7.1A Capacity: N/A and release to ASX Market Announcements 7 +Issue dates 27 December 2018 Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. Number +Class 8 Number and +class of all 53,956,335 Fully Paid Ordinary Shares +securities quoted on ASX ( including the +securities in section 2 if applicable)

  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

9
Number
and
+class
of
all
+securities not quoted on ASX
(including
the
+securities
in
section 2 if applicable)
Number +Class
22,184,259 Fully Paid Ordinary Shares
(escrowed until 29 January 2020)
6,405,409 Unlisted Options exercisable at
$0.553 expiring 31 March 2020
(escrowed until 29 January 2020)
9,929,329 Unlisted Options exercisable at
$0.553 expiring31 March 2020
2,378,198 Class
A
Employee
Options
exercisable at $0.533 expiring 30
June 2023
1,800,000 Class A Dir Performance Options
exercisable at $0.50 expiring 30
June2021.
300,000 Class B Dir Performance Options
exercisable at $0.55 expiring 31
December 2021.
300,000 Class C Dir Performance Options
exercisable at $0.60 expiring 31
December 2021.
300,000 Class DDir PerformanceOptions
exercisable at $0.65 expiring 31
December 2021.
300,000 Class EDir PerformanceOptions
exercisable at $0.80 expiring 31
December 2021.
300,000 Class FDir PerformanceOptions
exercisable at $0.95 expiring 31
December 2021.
300,000 Class GDir PerformanceOptions
exercisable at $1.10 expiring 31
December 2021.
  • 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No change.

Part 2 - Pro rata issue

  • 11 Is security holder approval N/A required?

  • 12 Is the issue renounceable or nonN/A renounceable?

  • 13 Ratio in which the[+] securities will N/A be offered

  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers
(or
subregisters)
be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

27
If the entity has issued options,
and the terms entitle option
holders to participate on exercise,
the date on which notices will be
sent to option holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements_in full_through a
broker?
31
How do security holders sell_part_
of their entitlements through a
broker and accept for the balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38 Number of[+] securities for which +quotation is sought 39 +Class of +securities for which quotation is sought

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class 42 Number and[+] class of all[+] securities quoted on ASX ( including the +securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 27 December 2018

(Company Secretary)

Print name: Henry Kinstlinger

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [403 x 406] intentionally omitted <==

----- Start of picture text -----

75,500,000
Insert number of fully paid [+] ordinary
(Date of first quotation – 29 January 2018)
securities on issue 12 months before the
+issue date or date of agreement to issue
Nil.
Add the following:
• Number of fully paid [+] ordinary
securities issued in that 12 month
period under an exception in rule 7.2
• Number of fully paid [+] ordinary
securities issued in that 12 month
period with shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities
cannot be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
Nil.
Subtract the number of fully paid
+ordinary securities cancelled during that
12 month period
75,500,000
“A”
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 11,325,000
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
75,283
(3B – 28 May 2018)
86,628
(3B – 31 August 2018)
478,683
(This 3B – 26 November 2018)
“C” 640,594
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
11,325,000
Subtract“C”
Note: number must be same as shown in
Step 3
640,594
Total[“A” x 0.15] – “C” 10,684,406
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

N/A “A” Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10

==> picture [387 x 26] intentionally omitted <==

----- Start of picture text -----

Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
----- End of picture text -----

==> picture [403 x 228] intentionally omitted <==

----- Start of picture text -----

N/A
Insert number of [+] equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as
separate line items
N/A
“E”
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A N/A “A” x 0.10 Note: number must be same as shown in Step 2 N/A Subtract “E” Note: number must be same as shown in Step 3 N/A Total [“A” x 0.10] – “E” Note: this is the remaining placement capacity under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 14

04/03/2013